SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-169301
Filing Date
2021-05-21
Accepted
2021-05-21 16:23:56
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d178552ds3.htm S-3 378409
2 EX-1.2 d178552dex12.htm EX-1.2 198802
3 EX-4.3 d178552dex43.htm EX-4.3 30401
4 EX-4.4 d178552dex44.htm EX-4.4 263211
5 EX-5.1 d178552dex51.htm EX-5.1 34285
6 EX-23.1 d178552dex231.htm EX-23.1 1894
7 GRAPHIC g178552g0521012202118.jpg GRAPHIC 3993
8 GRAPHIC g178552g29s30.jpg GRAPHIC 38862
9 GRAPHIC g178552g35m07.jpg GRAPHIC 45681
10 GRAPHIC g178552g37o48.jpg GRAPHIC 26989
  Complete submission text file 0001193125-21-169301.txt   1045112
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-3 | Act: 33 | File No.: 333-256378 | Film No.: 21949316
SIC: 2834 Pharmaceutical Preparations